Welcome to LookChem.com Sign In|Join Free

CAS

  • or

851785-70-1

Post Buying Request

851785-70-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851785-70-1 Usage

General Description

The chemical "(S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid" is a complex compound with several functional groups. It contains a carboxylic acid group, an amide group, a sulfone group, and a dichloro-substituted tetrahydroisoquinoline ring. The compound is a chiral molecule with an (S) stereochemistry at the 2-position. It is a potential pharmaceutical compound, as it contains structural features commonly found in drugs and bioactive molecules. The specific biological activities and potential therapeutic applications of this compound would need to be determined through further research and testing.

Check Digit Verification of cas no

The CAS Registry Mumber 851785-70-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,7,8 and 5 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 851785-70:
(8*8)+(7*5)+(6*1)+(5*7)+(4*8)+(3*5)+(2*7)+(1*0)=201
201 % 10 = 1
So 851785-70-1 is a valid CAS Registry Number.

851785-70-1Relevant articles and documents

NOVEL PROCESS FOR THE PREPARATION OF LIFITEGRAST

-

Page/Page column 20, (2019/05/02)

The present invention relates to a novel process for the preparation of lifitegrast of Formula (I). The present invention further provides a novel process for the purification of lifitegrast of Formula (I).

MODULATORS OF CELLULAR ADHESION

-

Page/Page column 94, (2010/02/11)

The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 851785-70-1